Different Aminoglycoside-Resistant Phenotypes in a Rabbit Staphylococcus aureus Endocarditis Infection Model

AUTOR(ES)

Asseray, N.

FONTE

American Society for Microbiology

RESUMO

The impact of different types of enzymatic resistance on the in vivo antibacterial activity of aminoglycosides (amikacin, gentamicin, and netilmicin) was studied in the rabbit endocarditis model with four strains of Staphylococcus aureus. Animals were treated in a manner simulating the administration of a single daily human dose. Amikacin had no effect on the three kanamycin-resistant strains despite apparent susceptibility in the disk diffusion test. Gentamicin appears to be the preferable aminoglycoside for treatment of staphylococcal infections.

Documentos Relacionados

• Aminoglycoside-resistant enterococci.
• Gentamicin Uptake in Wild-Type and Aminoglycoside-Resistant Small-Colony Mutants of Staphylococcus aureus
• Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
• Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
• Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium.